Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Leukemia
  •  Radiation Therapy
  •  Thoracic Oncology
  •  Pancreatic Cancer
  •  Immunotherapy
  •  Hormone Therapy
  •  Chemotherapy and Radiotherapy
  •  Adjuvant Therapy


Citation: Clin Oncol. 2022;7(1):1936.DOI: 10.25107/2474-1663.1936

Research Progress on the Origin and Mechanism of Liver Cancer Stem Cells

Juan Xu, Qing-Wei Cong and Ying Zhu

Department of Infectious, Liver Disease Center of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Dalian Medical University, China

*Correspondance to: Ying Zhu 

 PDF  Full Text Review Article | Open Access


Hepatocellular Carcinoma (HCC) is one of the most common malignancies in the world and it is highly fatal. Liver Cancer Stem Cells (LCSCs) are a kind of cell with resembling characteristics to normal stem cells in HCC. The self-renewal, differentiation, tumorigenic potential and chemical resistance of LCSCs may be responsible for the high recurrence rate and refractory of HCC. In
recent years, an accumulation of studies has shown that LCSCs originate from Hepatic Progenitor Cells (HPCs), hepatocytes, liver cancer cells and extrahepatic stem cells, and find that these cells transform into LCSCs through signaling pathways, gene mutation and other mechanisms. This paper reviews the original cells of LCSCs and their transformation mechanisms discovered in the last decade. In addition, in the process of HPCs and hepatocytes transforming into LCSCs, there is a cross-connecting network between the signaling pathways, which will provide some valuable clues for the targeted therapy of LCSCs.


Hepatocellular carcinoma; Liver cancer stem cells; Origin; Mechanism

Cite the Article:

Xu J, Cong Q-W, Zhu Y. Research Progress on the Origin and Mechanism of Liver Cancer Stem Cells. Clin Oncol. 2022;7:1936..

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

A Randomised Controlled Trial to Determine the Effect of Triptorelin on Reduction of Prostate Volume PreRadiotherapy Compared with Standard Therapy (Goserelin)
 Abstract  PDF  Full Text
Thromboxane-Prostanoid Receptor Signaling as Potential Therapy for Pulmonary Fibrosis
 PDF  Full Text
View More...